Patrick G Yeni

Summary

Country: France

Publications

  1. ncbi Update on HAART in HIV
    Patrick Yeni
    Hopital Bichat Claude Bernard, 46, rue Henri Huchard, 75877 Paris Cedex 18, France
    J Hepatol 44:S100-3. 2006
  2. ncbi Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel
    Patrick G Yeni
    Hopital Bichat Claude Bernard, Department of Infectious Diseases, 46 rue Henri Huchard, Paris, Cedex 18 France 75877
    JAMA 288:222-35. 2002
  3. ncbi Tipranavir: a protease inhibitor from a new class with distinct antiviral activity
    Patrick Yeni
    CHU Bichat Claude Bernard, 46, rue Henri Huchard, 75877 Paris Cedex 18, France
    J Acquir Immune Defic Syndr 34:S91-4. 2003
  4. ncbi Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel
    Patrick G Yeni
    Department of Infectious Diseases, Hopital Bichat Claude Bernard, X Bichat Medical School, Paris, France
    JAMA 292:251-65. 2004
  5. ncbi Comparative biological and clinical outcomes after a switch from a virologically unsuccessful first protease inhibitor-containing antiretroviral combination to a 3-drug regimen containing efavirenz, nevirapine, or abacavir
    Sophie Abgrall
    Institut National de la Santé et de la Recherche Médicale U720, Universite Pierre et Marie Curie Paris 6, Paris, 75625, France
    Clin Infect Dis 44:120-7. 2007
  6. ncbi Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir
    Sophie Abgrall
    INSERM U720, Paris, France
    AIDS 20:2099-106. 2006
  7. ncbi Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel
    Scott M Hammer
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    JAMA 296:827-43. 2006
  8. ncbi Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel
    Martin S Hirsch
    Harvard Medical School, Boston, Massachusetts, USA
    Clin Infect Dis 47:266-85. 2008
  9. ncbi Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel
    Scott M Hammer
    Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, 630 W 168th St, New York, NY 10032, USA
    JAMA 300:555-70. 2008
  10. ncbi Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era
    Olivier Sitbon
    Service de Pneumologie Hôpital Antoine Béclère, 157 rue de la Porte de Trivaux, 92141 Clamart, France
    Am J Respir Crit Care Med 177:108-13. 2008

Detail Information

Publications10

  1. ncbi Update on HAART in HIV
    Patrick Yeni
    Hopital Bichat Claude Bernard, 46, rue Henri Huchard, 75877 Paris Cedex 18, France
    J Hepatol 44:S100-3. 2006
    ....
  2. ncbi Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel
    Patrick G Yeni
    Hopital Bichat Claude Bernard, Department of Infectious Diseases, 46 rue Henri Huchard, Paris, Cedex 18 France 75877
    JAMA 288:222-35. 2002
    ..These updated recommendations are intended to guide practicing physicians actively involved in human immunodeficiency virus (HIV)- and acquired immunodeficiency syndrome (AIDS)-related care...
  3. ncbi Tipranavir: a protease inhibitor from a new class with distinct antiviral activity
    Patrick Yeni
    CHU Bichat Claude Bernard, 46, rue Henri Huchard, 75877 Paris Cedex 18, France
    J Acquir Immune Defic Syndr 34:S91-4. 2003
    ..Tipranavir's robust activity against PI-resistant strains results from its molecular flexibility, which allows it to fit into the active pocket of the protease enzyme in viruses that have become resistant to other PIs...
  4. ncbi Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel
    Patrick G Yeni
    Department of Infectious Diseases, Hopital Bichat Claude Bernard, X Bichat Medical School, Paris, France
    JAMA 292:251-65. 2004
    ..Substantial changes in the field of human immunodeficiency virus (HIV) treatment have occurred in the last 2 years, prompting revision of the guidelines for antiretroviral management of adults with established HIV infection...
  5. ncbi Comparative biological and clinical outcomes after a switch from a virologically unsuccessful first protease inhibitor-containing antiretroviral combination to a 3-drug regimen containing efavirenz, nevirapine, or abacavir
    Sophie Abgrall
    Institut National de la Santé et de la Recherche Médicale U720, Universite Pierre et Marie Curie Paris 6, Paris, 75625, France
    Clin Infect Dis 44:120-7. 2007
    ..A switch to a protease inhibitor-sparing cART may be useful when a patient does not tolerate a first protease inhibitor-containing cART regimen...
  6. ncbi Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir
    Sophie Abgrall
    INSERM U720, Paris, France
    AIDS 20:2099-106. 2006
    ....
  7. ncbi Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel
    Scott M Hammer
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    JAMA 296:827-43. 2006
    ..The International AIDS Society-USA panel has updated its recommendations as warranted by new developments in the field...
  8. ncbi Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel
    Martin S Hirsch
    Harvard Medical School, Boston, Massachusetts, USA
    Clin Infect Dis 47:266-85. 2008
    ..As the roll out of antiretroviral therapy continues in developing countries, drug resistance monitoring for both subtype B and non-subtype B strains of HIV will become increasingly important...
  9. ncbi Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel
    Scott M Hammer
    Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, 630 W 168th St, New York, NY 10032, USA
    JAMA 300:555-70. 2008
    ....
  10. ncbi Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era
    Olivier Sitbon
    Service de Pneumologie Hôpital Antoine Béclère, 157 rue de la Porte de Trivaux, 92141 Clamart, France
    Am J Respir Crit Care Med 177:108-13. 2008
    ..The prevalence of HIV-associated pulmonary arterial hypertension (PAH) has not been evaluated since introduction of combined, highly active antiretroviral treatments...